Pharmanutra

Pre-Annual General Meeting Information • Apr 5, 2023

Informazione Regolamentata n. 20106-19-2023		Data/Ora Ricezione 05 Aprile 2023 20:08:06	Euronext Star Milan
Societa'	:	PHARMANUTRA
Identificativo Informazione Regolamentata	:	174834
Nome utilizzatore	:		PHARMANUTRAN04 - Roberto Lacorte
Tipologia	:	REGEM
Data/Ora Ricezione	:	05 Aprile 2023 20:08:06
Data/Ora Inizio Diffusione presunta	:	05 Aprile 2023 20:08:07
Oggetto	:	PR - PHARMANUTRA - Pubblication of list and documentation for sharelholders'meeting
Testo del comunicato

Vedi allegato.

PHARMANUTRA S.P.A.: PUBLICATIONOF PROPOSED RESOLUTIONS AND PRESENTATIONOF THE LISTS OF CANDIDATES FOR APPOINTMENT OF THE BOARD OF DIRECTORS

PUBLICATIONOF OTHER SHAREHOLDER MEETING DOCUMENTATION

Pisa, 5 April 2023 – With reference to the Shareholders' Meeting of Pharmanutra S.p.A. convened for April 26, 2023 at 15:00 (the "Meeting"), it is noted that on March 31, 2023 the shareholders adhering to the Shareholders' Agreement, holders of a total of 3.253.826 shares equal to 33,61% of the subscribed and paid-up capital of Pharmanutra SpA - following the list for the appointment of the Board of Directors filed by them on 31 March 2023 - presented, within the terms and in the manner prescribed by law, the proposed resolutions relating to points 3.1 and 3.2 on the agenda of the Assembly and therefore the determination of the number of members and the determination of the term of office.

The list presented includes the following candidates:

• ✓ Andrea Lacorte
• ✓ Roberto Lacorte
• ✓ Carlo Volpi
• ✓ Germano Tarantino
• ✓ Alessandro Calzolari
• ✓ Marida Zaffaroni
• ✓ Giovanna Zanotti

The list of candidates for the appointment of the members of the Board of Directors presented by the aforementioned shareholders adhering to the Shareholders' Agreement, together with the documentation required pursuant to the law and the Articles of Association, and the proposed resolutions presented by the same shareholders are available to the public at the headquarters of the Company, in Pisa (PI), Via delle Lenze n. 216 / b, on the website at www.pharmanutra.it (Corporate Governance Section - Shareholders' Meeting), as well as at the authorized storage mechanism eMarket Storage at .

Pharmanutra S.p.A. also announces that the Directors' Report on point no. 4 of the agenda of the Shareholders' Meeting, as well as the Report on the remuneration policy and remuneration paid drawn up pursuant to Articles 123- ter of the Legislative Decree. 58/1998 and 84-quater of Consob Regulation no. 11971/1999, are available at the registered office in Pisa, via delle Lenze 216 / b, on the Company's website www.pharmanutra.it in the Governance/Shareholders' Meeting section, as well as at the authorized storage mechanism "eMarket Storage" which can be consulted at website .

PharmaNutra S.p.A.

Founded and led by Chairman Andrea Lacorte and Vice Chairman Roberto Lacorte, PharmaNutra, was established in 2003; with a national widespread presence and in more than 60 countries, it develops unique nutraceuticals and innovative medical devices, overseeing the entire production process from the proprietary raw materials to the finished product. PharmaNutra is the leading producer, with the SiderAL® trademark, of iron-based nutritional supplements, a field where it holds important patents on Sucrosomial® Technology, and is regarded as one of the top emerging players in medical devices for the rehabilitation of joint capacity thanks to the Cetilar brand.

For further information:

Via Delle Lenze, 216/b - 56122 Pisa Tel. +39 050 7846500 investorrelation@PharmaNutra.it

Internal Press Office press@calabughi.com

PharmaNutra S.p.A. Press Office - Spriano Communication & Partners

Via Santa Radegonda, 16 - 20121 Milan Tel. +39 02 83635708

Matteo Russo mrusso@sprianocommunication.com Cristina Tronconi ctronconi@sprianocommunication.com